The formation of protein coronas on nanoparticles (NP) has been investigated almost exclusively in serum, despite the prevailing route of exposure being inhalation of airborne particles. In addition, an increasing number of nanomedicines, that exploit the airways as the site of delivery, are undergoing medical trials. An understanding of the effects of NPs on the airways is therefore required. To further this field, we have described the corona formed on polystyrene particles with different surface modifications and on titanium dioxide particles when incubated in human bronchoalveolar lavage fluid (BALF) from patients with protein alveolar proteinosis (PAP). We show, using highresolution quantitative mass spectrometry (MS   E   ) , that a large number of proteins bind with low copy numbers but that a few 'core' proteins bind to all particles tested with high fidelity, averaging the surface properties of the different particles independent of the surface properties of the specific particle. The averaging effect at the particle surface means that differing cellular effects may not be due to the protein corona but due to the surface properties of the nanoparticle once inside the cell. Finally, the adherence of surfactant associated proteins (SP-A, B and D) suggests that there may be interactions with lipids and pulmonary surfactant (PSf), which could have potential in vivo health effects for people with chronic airway diseases such as asthma and chronic pulmonary obstructive disease (COPD), who have increased susceptibility toward other respiratory diseases.
Introduction
Epidemiological studies have demonstrated a link between airborne particulate matter and increased morbidity and mortality (Laden et al. 2000; Laden et al. 2006; Pope et al. 2004; Samet et al. 2000) . In light of this and increased usage of nanoparticles (NPs) in modern composite materials, including application of nano-sized therapeutics (Schütz et al. 2013) , numerous studies are aimed at understanding the fate and cellular toxicity of nanoparticles (NPs <100 nm) (Commission 2011) . Inhaled NPs may reach the lower lung alveolus (Oberdörster et al. 2005) where the particles can interact with pulmonary surfactant (PSf) (Schleh & Hohlfeld 2009 ), a single molecule layer of predominantly (90%) phospholipids and proteins (10%) (Pérez-Gil 2008) , before passing into the underlying hydrophase. In biological media, NPs rapidly become coated in proteins, which form a corona around their surface (Cedervall et al. 2007 ) and thus previously biologically inert particles may acquire a biological identity.
Surfactant associated proteins and lipids can bind to NPs (Kendall et al. 2012; Kendall 2007; Ruge et al. 2012) . Therefore, there is potential for NPs to have an in vivo effect on surfactant function. This is further evidenced through in silico modelling of surfactant function and NP translocation through the surfactant monolayer (Hu et al. 2013; Choe et al. 2008) . Metallic NPs may reduce the surface activity of model surfactant (Bakshi et al. 2008) , through mechanisms likely to be associated with adsorption of PSf components such as proteins (Fan et al. 2011; Dwivedi et al. 2014 ).
To date, many studies have investigated NP-protein interactions in serum, for which comprehensive lists of proteins that adsorb to the NP corona have been published (Tenzer et al. 2013; Cedervall et al. 2007; Schäffler et al. 2013) and it may be possible to predict the cellular fate of NPs from this data (Walkey et al. 2014) . However, there remains no analysis or identification of proteins bound to NPs in the context of the lung. This is likely due to the abundant and convenient availability of serum compared with a lung-related bio-fluid, for nanoparticle-protein kinetic studies.
Patients with pulmonary alveolar proteinosis (PAP) (Seymour & Presneill 2002) have reduced recycling and consequent build-up of PSf within their alveoli. The lipo-proteinaceous material may be removed through whole lung lavage which is typically performed during a single procedure, and can result in approximately 12-15 L of material per patient (Strong et al. 1998; Shah 2000) . This material differs from 'healthy' lung through increased levels of lipids and surfactant protein A (SP-A) (Honda 1993) and SP-D (Honda et al. 1995 ) with a 10-fold and 7-fold increase respectively. The proportion of SP-A to the total protein is similar between PAP and healthy control, suggesting that whilst the fluid may be more concentrated for lipids and proteins, the proportions of these proteins remains constant (Honda 1993) . Therefore, we believed that this media would be a useful source of pulmonary material for investigating NP-protein interactions within the context of the pulmonary system.
Using high resolution, quantitative mass spectrometry (MS E ), we describe the proteins from BALF binding to 3 polystyrene (PS) NPs with different surface modifications -aminated (aPS), carboxylated (cPS) and unmodified (uPS) -and one metal (TiO 2 ) and a time study of the corona formed around aPS and cPS. The research has demonstrated that only a few proteins bind to the NPs with high fidelity and do so regardless of particle surface functionality. Furthermore, we have observed the adherence of surfactant associated proteins (SP-A, SP-B and SP-D) binding to the surface of the particles, suggesting a mechanisms through which inhaled NPs may affect health. 
Methods
For full method descriptions, see Supplementary Methods. Nanoparticles 100 nm polystyrene (PS) were purchased from Polysciences Incorporated (Germany) and TiO 2 particles from Evonik Industries (UK). Particles were stored at 4 o C and were handled in a class 2 safety cabinet to maintain their sterility.
Dynamic Light Scattering and Zeta Potential
Hydrodynamic diameter and zeta potential (ZP) measurements were acquired at 37 O C. 5 cm 2 of nanoparticles were suspended in 1 mL of PBS. We were not able to take comparable measurements in BALF due to health and safety concerns about the risk of contamination of the apparatus from unscreened human material.
Cell Culture and Cellular Assay A549 cells were treated with BALF-coated or untreated NPs for 24 hours. Mitochondrial activity was assessed by the cells ability to reduce MTT to insoluble formazan, the concentration of which was determined by absorbance at 550 nm.
Bronchoalveolar Lavage Fluid and Corona Formation
Bronchoalveolar lavage fluid (BALF) was acquired by therapeutic lung lavage from a patient suffering pulmonary alveolar proteinosis (PAP) with informed consent under approved ethics (NRES reference 10/H0504/9). Approximately 13 L was acquired from a single patient and the first 4 L were pooled and aliquoted prior to freezing at -20 o C. Before incubating the particles, the BALF was defrosted and briefly centrifuged at low speed to pellet large agglomerates and cellular debris before being centrifuged for 30 minutes at 10,000 x g to remove smaller agglomerates.
For LC-MS analysis of the proteins corona, 50 cm 2 of particles were incubated in 20 mL (approximately 5 mg total protein) of BALF for 15, 30, 60 or 120 minutes. For cellular assays, 500 cm 2 of particles were suspended in 30 mL of BALF for 60 minutes. Particle-BALF mixtures were centrifuged at 10,000 x g for 30 minutes to pellet the NPs, which were either washed 5 times with 1 mL phosphate buffered saline, centrifuging for 15 minutes at 17,000 x g (for corona analysis) or diluted to relevant concentrations by serial dilution in serum-free media for cellular assays.
LC-MS E
Particles were run into an SDS PAGE gel for 10 minutes to elute the proteins. Each lane was then excised and cut into approximately 1 mm 3 pieces and in gel reduction, alkylation and tryptic digestion performed. Peptides were extracted using 1% (v/v) formic acid, and 2% (v/v) acetonitrile in 25 mM ammonium bicarbonate buffer. Samples were analysed by LC-MS E in resolution mode (Acuity UPLC M-Class, Synapt G2S, Waters) over a 30 minutes gradient of acidified (0.1% v/v formic acid) acetonitrile (3-40%).
Protein Identification, Bioinfomatics and Statistics Database searching and quantification was performed in ProteinLynx Global Server version 3.0 (Waters), searching against human SwissProt (UniProt). Protein characteristics were extracted from ProtParam (ExPAsy).
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Results
Particle Characterisation Nanoparticles were thoroughly characterised by dynamic light scattering, electron microscopy and atomic force microscopy . Since agglomerated particles were not monodispersed, as is assumed by DLS, we have reported their size by 'number' (for z-averages, see supplementary table ST1). All particles increased in size following incubation in BALF. Both aPS and TiO 2 particles formed large agglomerates in BALF (approximately 90 % and 439 % increase in size, respectively, by TEM), whereas cPS and uPS were more stable (supplementary table ST2). Since size was variable depending on method used to measure them and their suspension media, we used 100 nm (manufacturers label size) for surface area calculations of the polystyrene and 14.09 nm for TiO 2 . For all particles, zeta potential was negative, with aPS least negative, followed by uPS, cPS and TiO 2 (-11.5mV, -17.07, -19.73 and -22.7mV respectively) in PBS (pH 7.4). Owing to the agglomeration of aPS and TiO 2 in BALF, we incubated the particles in large volumes (20-30 mL) of BALF to minimise the agglomeration.
Particle toxicity was determined following cellular exposure to BALF-incubated or non-incubated particles at a range of concentrations for 24 hours (Figure 1 ). Both BALF coated and uncoated aPS particles decreased the reduction of MTT in living cells when added at high concentrations. Uncoated particles caused a statistically significant decrease by 100 cm 2 /mL whereas uncoated particle did not reach significant levels ( Figure 1A ). The addition of uncoated cPS particles caused a large increase in absorbance, whereas coated particles caused no deviation from untreated cells ( Figure 1B) . Uncoated uPS particles also caused a statistical increase, whereas there was no change when the particles had been pre-incubated in BALF ( Figure 1C) . In contrast, TiO 2 particles caused no effect when uncoated, however, BALF-incubated particles caused an increase at concentrations of 1 cm 2 /mL and below. It was observed that at low concentrations (0.01-1 cm 2 /mL), there was an increase in mitochondrial activity as observed by higher levels of insoluble fomazan. Preliminary experiments were performed showing no effect of the particles on MTT reduction, nor any effect of BALF at 1% (v/v) concentration (data not shown).
Bronchoalveolar Lavage Fluid
The protein concentration of BALF was determined after a freeze thaw cycle and after centrifugation at 10,000 x g for 30 minutes to be approximately 251 µg/mL. After the same treatment, phospholipid content was determined to be below the detectable range of the assay (< 10 µg/mL).
Protein Corona
As different modifications can lead to different cellular effects, we wished to determine if this was also true for the proteins that bound to the surface of the particles. We determined, by SDS PAGE and BSA assay, that 5 washes were sufficient to remove non-bound proteins (Supplementary figure S1).
Corona proteins from both aPS and cPS particles, incubated for 15, 30, 60 or 120 minutes were identified and quantified to gain an insight into the dynamics of protein-particle interactions on a time scale relevant in vivo (Supplementary File SF1 and SF2). The corona of TiO 2 and uPS particles were also analysed after 60 minutes incubation in BALF (SF3). Proteins were normalised by dividing each sample by the sum of proteins (fmol) present in at least 90 % of all samples and identifications were accepted if they were detected in at least two repeats of a single time point (i.e. a subsequent identification of a bound protein in only 1 repeat was allowed provided at a different time point it J U S T
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was detected in at least 2 repeats). Quantifications were only accepted if they were present in at least 2 repeats for each individual time points.
The number of particles per molecule (calculated by dividing the number of molecules (mols*Avogadro's number) by the number of particles) were consistant for cPS particles over the time course analysed, with an average of 400 protein molecules per particle (supplementary figure  S2A) . The number of molecules per particle for aPS averaged at 517, but, unlike cPS, was not a constant value, peaking at 30 minutes before dropping at 60 and 120 minutes. There was, however, large variation at 30 and 60 minutes, suggesting that the evolution of the corona may be changeable. When incubated for 60 minutes, carboxylated particles bound statistically fewer molecules than aPS or uPS (P = 0.006 and 0.042, respectively), TiO 2 bound more molecules, although not statistically so (supplementary figure S2B). Aminated and carboxylated polystyrene particles and TiO 2 particles bound similar numbers of molecules (aprox. 700) despite there being orders of magnitude difference in their sizes.
The protiens binding to aPS and cPS particles were investigated over time. There were 34 and 32 proteins detected that were common to all time points for aPS and cPS respectively (Figure 2) , however, over time, both changed, with unique proteins being detected at all time points for aPS particles and at 30 minutes and 120 minutes for cPS particles. Of the proteins shared at all time points, 16 were quantified for aPS and cPS. These proteins changed very little over time and in general were present in high abundance on the particles (Figure 2C and D).
To determine if the proteins were binding in a concentration-dependant manner -i.e. if the most abundant proteins in BALF were the most abundant proteins bound to the particles, BALF was also analysed by LC-MS E (SF4). The distribution of BALF proteins identified were ordered by their abundance, with the overall top 20 proteins found bound to the particles highlighted in red ( Figure  3) . This showed that the most abundant proteins in the corona were not necessarily the most abundant in BALF and this was the case for all particles. Furthermore, there was high conservation of the corona at each time point for aPS and cPS ( Figure 3A and B) . Not all the proteins detected on the particles were identified in BALF, showing that proteins present in low amounts in bodily fluids can become concentrated on the particles. This suggests that there might be a physiochemical feature of the proteins driving their adhesion to the particles and vice versa.
We investigated various properties of the bound proteins bioinfomatically, weighting by their abundance (Figure 4) . The bound proteins were, in general, small (< 80 kDa), hydrophilic and acidic with little change in the average characteristics over the time course or between particles, although aPS particles bound proteins with a slightly higher GRAVY score (hydophobic). Principle Component Analysis (PCA) analysis of the unique proteins bound to each particle at 60 minutes was not able to discriminate between the particles based on their physical characteristics (data not shown).
It was evident that the protein corona is relatively dynamic over time and cluster analysis grouping proteins by binding-pattern, identifying four distinct groups for aPS ( Figure 5A ) and cPS ( Figure 5C ).
The physiochemical properties of the bound proteins were plotted using a PCA analysis which was then coloured according to the cluster the protein conformed to. This analysis did not highlight any relationship between their biophysical characteristics and their binding moiety.
There were differences in the identity of the bound proteins between aPS and cPS over time ( Figure  2A and B) and all particles (SF1, 2 and 3) that was not reflected in the bioinfomatic data. This could be due to skewing by the abundant proteins. On average, less than 1% of the bound protein at any time point accounts for 20% of the total proteins present, and 20% of the bound proteins account
for 60 % of the total protein corona (Figure 6 ). Over time, the distribution of proteins bound to aPS particles changed very little, whereas for cPS particles, after 60 minutes, the proportion of protiens changed such that the percetage of proteins responsible for 80% of the total bound protein increased from 50% to 60%. Furthermore, there is strong conservation between the top 5-10 proteins bound to aPS ( Table 2 ) and cPS (Table 3 ) over time as well as to all particles ( Table 1) .
Discussion
Zeta potential readings of these particles were all less than 0 mV. Even for aPS particles that carry a positively charged functional group, the overall charge was negative, suggesting a low concentration of surface groups. Since the zeta potential of all the particles was quite close, any differences observed in the protein corona between PS particles are probably not a consequence of surface charge, but due to the functional groups.
We identified a number of intracellular proteins from BALF which we would not expect to be present in a healthy lung and may be a result of mechanical agitation of lung tissue whilst acquiring the lavage. The presence of serum proteins suggests some degree of leakage into the lung from the underlying vasculature which it is likely also a common in vivo occurrence (Ward et al. 1997) , although may also be exacerbated by mechanical agitation.
Lactose dehydrogenase (LDH) and MTT assays are commonly performed to assay the toxicity of NPs. It has been observed by ourselves (e.g. Table 1 ) and that LDH binds to particles and therefore could interfere with this assay. For this reason, we used the MTT assay, which is a measure of mitochondrial activity, to investigate particle toxicity (Weyermann et al. 2005; Mosmann 1983 ). It has been observed across the literature that cationic particles, including polystyrene, are toxic to cells (Wang, Yu, et al. 2013) , as observed similarly here with aPS particles (Figure 1A) , where coating the particles decreased, but did not oblate their toxicity. Similar observations were made for cPS and uPS particles, where coating them with BALF decreased any differences in cellular activity between exposed and non-exposed particles. Given the increase was present at very low concentrations, we hypothesised that this increase could be due to a secreted factor in response to particulate exposure that may propagate an energy-dependent reaction, such as an inflammatory mechanism, within the cells. We therefore investigated a number of proinflammatory cytokines by quantitative-PCR, but found no increased levels of mRNA for interleukin (IL)-4, IL-6 or tumour necrosis factor receptor 1 (data not shown). When coated in BALF, there was no change in cellular response for either cPS or uPS, suggesting that these particles were biologically inert to A549 cells, which may be true in vivo, or the concentration of the particles used in the assay was below what is required for an acute inflammatory response from this cell line. TiO 2 particles did not have any effect on mitochondrial activity when they were uncoated, however, there was an increase in insoluble formazan of approximately 50% at low concentrations for BALF-coated, showing different behaviour from cPS and uPS particles.
In vivo, particles become rapidly coated in proteins and lipids, and this process has been extensively studied in serum and media . The primary route of exposure to airborne particles is due to inhalation and therefore studies in serum may not be relevant to environmental (pollutant) or inhaled nanotherapeutics (Wittgen et al. 2007 ). Therefore, we investigated the protein corona of NPs in BALF, which contains aqueous material from the lining fluid of pulmonary alveoli. Frequently, descriptions of protein coronas do not contain quantitative information of individual proteins and therefore analysis of the protein characteristics of the NP corona does not account for individual proteins present in high abundance. We have described the NP corona using high resolution MS to J U S T
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obtain quantitative information that we have used to weight the particle descriptions, thereby describing a more accurate representation of the particle corona.
The number of proteins bound to the particles was variable over time, particularly for aPS particles, (supplementary figure S2) upon which the number of proteins varied between 300 and 1000 per particle, suggesting highly dynamic binding kinetics. As discussed later, a relatively small number of proteins account for a large percentage of the corona and therefore this variability may be dictated by low abundance proteins. The TiO 2 particles bound a similar number of proteins per particle compared with large polystyrene NPs despite being approximately 7x smaller and therefore having in the order of 49x less surface area per particle. The size of TiO 2 NPs, as determined by TEM, was approximately 14 nm in PBS, however, by hydrodynamic diameter this was measured at 186 nm, suggesting agglomeration in solution. Therefore, it is possible that the number of particles present in the TEM samples was an underestimation, the variation in size making the calculation error prone for TiO 2 (the polystyrene particles were more homogenous and therefore the number of particles is more reliable for these particles).
There were few differences in the corona between any of the particles at any time points (Figure 4 ) and therefore it is unlikely that the protein corona formed within the lung would predict cellular uptake as reported elsewhere (Walkey et al. 2014) . The proteins tended to be acidic and hydrophilic, although BALF may be enriched for such proteins as it is obtained using aqueous saline solution. There was conservation between the most abundant corona proteins, not only through time, but also between different particles (Table 1-3) , suggesting that there is a small subset of proteins that dominate the protein corona. We investigated the composition of BALF to see if they bound through a concentration dependant manner, or if there could be a bio-physical attraction driving their adherence. The most abundant proteins on the corona were not necessarily the most abundant in BALF (Figure 3) although they tended to be amongst the top 50% of BALF-proteins. Not all of the proteins identified on the particles were identified in BALF alone, which suggests an enrichment of low abundance proteins on the particle surface (Bantscheff et al. 2007 ). The Vroman theory of protein exchange at hydrophobic surfaces, where high abundance, low affinity proteins are be exchanged over time for more strongly adherent but lower abundance proteins (Vroman 1962; Vroman & Adams 1969) , has been applied to NP-protein interactions (Casals et al. 2010; Jung et al. 2003) . In part, our data supports this, since we see some proteins that are in high abundance in BALF also on the particles, but, analysis over time showed that these proteins were not exchanged. It has been demonstrated in serum that a stable corona can be formed in under 2 minutes (Dobrovolskaia et al. 2014; Tenzer et al. 2013) . Our data shows that after 15 minutes, there is very little change in most of the protein bound to the particles, but there is change in the lower abundance proteins. Furthermore, clustering analysis demonstrated that there was not simply an on-off exchange of proteins but a number of distinct modalities and that protein binding could not be predicted based on their physiochemical properties . This finding may not be surprising when considering the scale between the nanoparticle and a protein. SP-A, one of the most abundant protein identified is approximately 40 nm in length and therefore is similar size to the PS and TiO 2 particles used here. Therefore it is unlikely that the affinity of single functional groups will contribute greatly to the binding of the protein, rather the avidity of the particle surface.
Since the NPs coronae are similar the effects on MTT reduction may be independent of the NP corona (Ehrenberg et al. 2009 ), in keeping with lysosomal-bursting hypothesis of cationic particle toxicity (Bexiga et al. 2011; Wang, Bexiga, et al. 2013) .
Bronchoalveolar lavage fluid is a mixture of lipids and proteins, therefore lipids maybe binding at the particle surface. The concentration of phospholipids, the predominant lipid species (Pérez-Gil 2008) J U S T A C C E P T E D was determined to be <10 µg/mL, therefore protein was in large excess in comparison. That said, proteins known to interact with pulmonary lipids, such as SP-A, SP-B (Table 3) and SP-D (SF1) were found on the particles' surface. SP-A and SP-D have been shown to bind to NP particles and affect their phagocytosis Kendall et al. 2012 ).
Here we show that the particles may bind these proteins in vivo. In particular, SP-A was present in high abundance on all particles. SP-A has multiple functions in innate immunity, PSf spreading and recycling (Kishore et al. 2006 ). SP-B, which was also observed to bind to NPs is a hydrophobic protein that interacts and assists spreading of PSf to maintain low surface tension (Schürch et al. 2010) . Hence, sequestering of these surfactant proteins could have an influence of the surface tension lowering properties of surfactant. Furthermore, as discussed in the introduction, airborne NPs have been shown to have a detrimental effect on mortality, particularly amongst people with respiratory diseases (Kendall & Holgate 2012; Mackay et al. 2016) . Mice made deficient for SP-A or SP-D have impaired surfactant metabolism and substructures (Korfhagen et al. 1998; Botas et al. 1998 ) and an impaired innate immune defence against bacterial and viral infections (Korfhagen et al. 1996; Pastva et al. 2007 ).
At the air-liquid interface of the lung, PSf is a barrier to nanoparticle entry into the hydrophase. Nanoparticles can/must pass through this before reaching the hydrophase beneath (Choi et al. 2010; Hu et al. 2013) . Particles have been shown to bind to lipids from this layer (Kendall 2007; Ruge et al. 2012; Gonzalez et al. 1991 ) therefore inclusion of this layer is essential for a full description of nanoparticle-interactions with pulmonary fluids (Schleh et al. 2013 ). The BALF used throughout these experiments contained trace lipids species that could be identified by mass spectrometry (data not shown) and we observed the binding of proteins known to interact with PSf lipids. Nanoparticles have been shown to affect the functioning of PSf monolayers in vitro (Beck-Broichsitter et al. 2011; Dwivedi et al. 2014 ) and in silico (Hu et al. 2013; Lin et al. 2014) , therefore future work would benefit from including a full description of the lipid corona.
The BALF used was taken from patients with pulmonary alveolar proteinosis (PAP), a disease characterised by a reduction in clearance of PSf and consequently is rich in lipids and surfactant associated proteins (Seymour & Presneill 2002; Shah 2000) . The presence of SP-A as a dominant protein on the particles' surface may be as a consequence of its exaggerated abundance in PAP-BALF, in which it is known to be high. However, in the analysis of BALF only, it was only the 50 th most concentrated protein detected (Figure 3, Q8IWL1) . Therefore there may also be significant binding of SP-A in non-PAP BALF, particularly as it is profuse in PSf.
Conclusion
A nanoparticle-surface corona forms quickly and stably following their incubation in BALF. Few proteins are bound in very high abundance on the surface, but those that are, are conserved over time and between particle types. The binding of proteins is independent of particle functionalisation, such upon inhalation, nanoparticle surfaces will become averaged, regardless of their intrinsic properties. We have detected the presence of PSf lipids binding to the surface of the particles (data not shown) that may further abrogate the intrinsic characteristics of the particle; this is currently under further investigation. We observe that there is a potential for pathological effects due to binding of surfactant-associated proteins and lipids to the particle surface. 
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Figure 6:
The distribution of the abundance of proteins for each particle corona. aPS and cPS particles were incubated for the time shown on the x-axis whereas uPS and TiO 2 were incubated in BALF for 60 minutes only.
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